2021
DOI: 10.1186/s12933-021-01227-4
|View full text |Cite
|
Sign up to set email alerts
|

Correction to: Reduced oxidized LDL in T2D plaques is associated with a greater statin usage but not with future cardiovascular events

Abstract: An amendment to this paper has been published and can be accessed via the original article.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 1 publication
(1 reference statement)
0
2
0
Order By: Relevance
“… 33 And abnormal LDL is an important factor in CAS. 34 However, in our present research, we have not been able to explore the correlation between miR-19a-3p and clinical indicators including LDL in time, which is a major defect of this study. We will continue to focus on this issue in the future.…”
Section: Discussionmentioning
confidence: 75%
“… 33 And abnormal LDL is an important factor in CAS. 34 However, in our present research, we have not been able to explore the correlation between miR-19a-3p and clinical indicators including LDL in time, which is a major defect of this study. We will continue to focus on this issue in the future.…”
Section: Discussionmentioning
confidence: 75%
“…Previous studies done on LDL in T2D plaque is associated with cardiovascular events [9], nonalcoholic fatty liver disease leads to cardiovascular events [10], cardiovascular safety of mometasone and once-daily fixeddose [11], atherosclerosis leads to process, indicators, risk factors and new hopes [1] advances in new therapeutic targets [12], pathology of atherosclerosis plaque development and plaque responses to medical treatment [7,13,14]. The current study aimed to create awareness of atherosclerosis and cardiovascular events among healthcare professionals.…”
Section: Introductionmentioning
confidence: 98%